Fédération d'urologie, CHU Rangueil, 1, avenue Jean-Poulhes, 31403 Toulouse cedex, France.

This email address is being protected from spam bots, you need Javascript enabled to view it

To determine the survival and prognosis criteria of pT3NxM0 prostate tumours (TNM 2002) after radical retropubic prostatectomy (RRP).

Between 1988 and 2000, 606 consecutive RRP were performed for T1-3 tumours, whose 246 (40.6%) specimens were classified pT3, followed in 53 cases by adjuvant radiotherapy and in 71 cases by salvage radiotherapy. Fifty-five patients received postoperative hormonotherapy at the time of biochemical recurrence. Biochemical recurrence was determined by two PSA values greater than 0.2 ng/ml.

Mean age of this group was 65 years at surgery. Mean follow-up was 91.4 months. Mean preoperative PSA was 12.8 ng/ml. Distribution of cases was 170 pT3a (69.1%) and 76 (30,9%). At 10 years, the biochemical progression-free, metastasis-free, specific and overall survival was 54, 86, 92 and 75% respectively. Worse biochemical prognostic factors were lymph node extension, high Gleason score, high preoperative PSA, seminal vesicles involvement, positive surgical margins and adjuvant radiotherapy absence.

This study shows that pT3 tumours treated with therapeutic associations including RRP presents an excellent specific survival at 10 years. The determination of biochemical recurrence prognostic factors could help to select patients who need complementary treatments after surgery.

Article in French

Written by:
Roche JB, Malavaud B, Soulié M, Cournot M, Gamé X, Mazerolles C, Bachaud JM, Plante P, Rischmann P. Are you the author?

Reference:
Prog Urol. 2008 Oct;18(9):586-94.
doi:10.1016/j.purol.2008.05.003

PubMed Abstract
PMID:18986631

UroToday.com Prostate Cancer Section

Please log-in or register in order to submit comments.

Powered by AkoComment!